About this trial
The collaborative care model (CCM) is a health services intervention that integrates mental health care in primary care settings. The goal of this study is to adapt the CCM to the perinatal care context, including community co-designed adaptations to enhance health equity (COMPASS+). The main objectives of the study are to:
1. Evaluate the effect of COMPASS+ on depression symptom outcomes. Specifically we will evaluate population-level depression symptom trajectories and the prevalence of suicidal ideation among. We will also measure rates of depression response and remission for those who have elevated screen scores (i.e., PHQ9 ≥ 10) 2. Adapt, optimize, and evaluate COMPASS+ implementation strategies to the unique context of perinatal care and evaluate implementation outcomes. The RE-AIM framework will be used to evaluate implementation outcomes (acceptability, appropriateness, feasibility, and fidelity). We hypothesize that variability in effectiveness outcomes will be attributable to variability in fidelity to the implementation strategies or in implementation outcomes. 3. Identify the effect of COMPASS+ on perinatal depression and implementation outcomes across racial and ethnic subgroups.
Eligibility criteria
Qualifiers
all pregnant and postpartum people receiving care at participating sites, who reach a gestational age of 20 or more weeks
age > 17 years
Disqualifiers
age < 18 years
all pregnant and postpartum people receiving care at participating sites, who do not reach a gestational age of 20 or more weeks
Trial design
Treatments tested in this trial
- COMPASS+
Treatment groups
Sponsors and collaborators
Women and Infants Hospital of Rhode Island
Lead sponsor
Brown University
Collaborator
National Institute of Nursing Research (NINR)
Collaborator